The non‐haematopoietic biological effects of erythropoietin
Murat O. Arcasoy(Duke University)
Cited by 353
Related Papers
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I
|Haematologica|2013|162
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors
|Biology of Blood and Marrow Transplantation|2015|142